Engineering Functional Biomaterials for Targeted and Localized Cancer Drug Delivery: A Structure–Property–Performance Design Perspective
Open Access
- 21 September 2026
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (9) , 1498
Abstract
Background/Objectives: Cancer therapy remains limited by poor tumor selectivity, systemic toxicity, biological barriers to drug transport, rapid clearance, treatment resistance, and postoperative recurrence. Functional biomaterials offer engineered systems to address these limitations through targeted, localized, controlled, and stimuli-responsive drug delivery. However, existing reviews commonly classify these systems according to carrier type, therapeutic agent, or cancer application, with less emphasis on how biomaterial structure and physicochemical properties determine therapeutic performance. This review addresses this gap using a structure–property–performance (SPP) framework to rationally engineer functional biomaterials for targeted, localized cancer drug delivery. Methods: The review critically examines particle size and morphology, surface chemistry and charge, targeting functionalization, stimulus responsiveness, porosity and internal architecture, mechanical stability, and degradation, and relates these design parameters to drug loading and release, systemic transport, tumor accumulation and penetration, cellular uptake, and local retention. Selected mechanistic relationships, including equations for particle diffusion, membrane wrapping, receptor-mediated endocytosis, particle aspect ratio, porous-matrix transport, implant-associated tissue diffusion, and porosity-dependent stiffness, are also discussed to support quantitative interpretation of SPP relationships. The review further evaluates these relationships across cancer-specific biomaterial applications. Results: The reviewed evidence shows that biomaterial properties are strongly interdependent and often involve competing requirements, so optimizing one property can improve one aspect of therapeutic performance while limiting another. Cancer-specific applications in breast, brain, colorectal, pancreatic, melanoma, ovarian, bladder, and bone cancers further demonstrate that effective biomaterial design must be matched to disease-specific biological and anatomical barriers. Conclusions: The SPP framework provides a design approach for moving functional biomaterials from empirical formulation toward integrated, application-specific design. Future development is expected to increasingly incorporate AI-guided and personalized design, image-guided delivery, multi-responsive functionality, and integration of cancer therapy with tissue regeneration to advance more precise and clinically translatable cancer treatments.Keywords
All Related Versions
This publication has 208 references indexed in Scilit:
- Dual‐Functional Sonodynamic Therapeutic Platform for Complete Osteosarcoma Elimination With Synchronized Bone Defect RegenerationAdvanced Functional Materials, 2026
- Microglial Membrane‐Coated Biomimetic Nanoplatform for Enhanced Blood–Brain Barrier Penetration and Targeted Photodynamic Therapy in Orthotopic GlioblastomaAdvanced Healthcare Materials, 2025
- A landscape of recent advances in lipid nanoparticles and their translational potential for the treatment of solid tumorsBioengineering & Translational Medicine, 2023
- Immunostimulant In Situ Hydrogel Improves Synergetic Radioimmunotherapy of Malignant Glioblastoma Relapse Post‐ResectionAdvanced Functional Materials, 2022
- Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019JAMA Oncology, 2021
- Combinatorial Photothermal 3D‐Printing Scaffold and Checkpoint Blockade Inhibits Growth/Metastasis of Breast Cancer to Bone and Accelerates OsteogenesisAdvanced Functional Materials, 2020
- NIR/ROS‐Responsive Black Phosphorus QD Vesicles as Immunoadjuvant Carrier for Specific Cancer Photodynamic ImmunotherapyAdvanced Functional Materials, 2019
- Integrating Artificial Intelligence and Nanotechnology for Precision Cancer MedicineAdvanced Materials, 2019
- Disulfide‐Bridged Organosilica Frameworks: Designed, Synthesis, Redox‐Triggered Biodegradation, and Nanobiomedical ApplicationsAdvanced Functional Materials, 2018
- Exploring Primary Liver Macrophages for Studying Quantum Dot Interactions with Biological SystemsAdvanced Materials, 2010